Who bought Alna stock in the last quarter?
ALNA stock was bought by a variety of institutional investors in the last quarter, including Altium Capital Management LP, GSA Capital Partners LLP, Two Sigma Securities LLC, Jane Street Group LLC, Quilter Plc, Natixis, Spire Wealth Management, and Geode Capital Management LLC.
Is Allena Pharmaceuticals (Alna) stock outpacing the S&P 500?
Allena Pharmaceuticals has received 68.08% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Allena Pharmaceuticals and other stocks. Vote “Outperform” if you believe ALNA will outperform the S&P 500 over the long term.
Is Allena Pharmaceuticals (Alna) ripe for a trend reversal?
The heavy selling pressure might have exhausted for Allena Pharmaceuticals, Inc. (ALNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
What price target do analysts set for Alna?
What price target have analysts set for ALNA? 5 brokers have issued 1-year price objectives for Allena Pharmaceuticals' shares. Their forecasts range from $5.00 to $18.00. On average, they anticipate Allena Pharmaceuticals' share price to reach $10.50 in the next year.
Why is ALNA stock falling?
Alnylam (ALNY) Misses on Q1 Earnings, Lowers '22 Revenue View. Alnylam's (ALNY) earnings and sales fall shy of estimates in the first quarter of 2022. The company cuts 2022 guidance for net product revenues. Shares down.
Will ALNA stock go back up?
The Wall Street analyst predicted that ALLENA PHARMACEUTICALS's share price could reach $0.50 by Mar 22, 2023. The average ALLENA PHARMACEUTICALS stock price prediction forecasts a potential upside of 342.48% from the current ALNA share price of $0.11.
Is ALNA stock a good buy?
Allena Pharmaceuticals has 327.35% upside potential, based on the analysts' average price target. Can I see which stocks the top-ranking analysts are rating? Yes, go to the Analysts' Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
Who owns ALNA stock?
The 3.99% of ALNA shares held by institutional investors is a greater percentage than is typically held for stocks in the Pharmaceuticals: Major industry....Top 10 Owners of Allena Pharmaceuticals Inc.StockholderFidelity Management & Research Co...Stake0.10%Shares owned106,183Total value ($)12,5309 more columns